Advanced in Acute Myeloblastic Leukemia without Maturation

Xiaojun W. Huang

Xizhimen Nan Street No.11, 
Xizhimen, CN 
Advanced in Acute Myeloblastic Leukemia without Maturation
Xizhimen Nan Street No.11, 
Xizhimen, CN 
OverviewLocationsClinical Research

Overview

Xiaojun Huang practices in Xizhimen, China. Huang is rated as an Advanced expert by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Their top areas of expertise are Leukemia, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Their clinical research consists of co-authoring 365 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Acute Myeloblastic Leukemia without Maturation.

Locations

Xizhimen Nan Street No.11, Xizhimen, 100044, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Risk Stratification-directed N-acetyl-L-cysteine for Prevention of Poor Hematopoietic Reconstitution After Unmanipulated Haploidentical Stem Cell Transplantation--an Open-label, Randomized, Controlled, Clinical Trial
Risk Stratification-directed N-acetyl-L-cysteine for Prevention of Poor Hematopoietic Reconstitution After Unmanipulated Haploidentical Stem Cell Transplantation--an Open-label, Randomized, Controlled, Clinical Trial
Enrollment Status: Unknown
Publish Date: September 14, 2021
Intervention Type: Drug
Study Drug: N-Acetyl-L-Cysteine
Study Phase: Phase 3
Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors
Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

365 Total Publications

Analysis and prediction of prevalence, disease burden of type 2 diabetes mellitus and risk factors in China from 1990 to 2021 in a global context
Analysis and prediction of prevalence, disease burden of type 2 diabetes mellitus and risk factors in China from 1990 to 2021 in a global context
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Huang's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile